Sara Mingdan Deng

Senior scientist, Project leader | Three U.S. FDA Orphan drug designations; Three Rare Pediatric Disease Designations; One PIND/IND under preparation

Hong Kong, Hong Kong SAR

About

Obtain: FDA orphan drug designation of progressive familial intrahepatic cholestasis (PFIC); 19 November 2024; https://www.innorna.com/news/336.html FDA RPD designation of progressive familial intrahepatic cholestasis (PFIC); 1 November 2024; https://www.innorna.com/news/326.html FDA orphan drug designation of Progressive Familial Intrahepatic Cholestasis (PFIC); 30 July 2024; https://www.innorna.com/news/322.html FDA orphan drug designation of classic homocystinuria (HCU); 19 July 2024; https://www.innorna.com/news/311.html FDA RPD designation of Progressive Familial Intrahepatic Cholestasis (PFIC); 10 July 2024; https://www.innorna.com/news/307.html FDA RPD designation of classic homocystinuria (HCU), a serious or life-threatening genetic disease ; l5 July 2024; https://www.innorna.com/news/301.html Previous publications: Loh, Jia Jian; Ng, Kai Yu; Huang, Ianto Bosheng; Deng, Mingdan; Wang, Yanyan; Man, Ki Fong; Lam, Ka Hei; Lee, Terence Kin-Wah; Tan, Jia Yan; Cui, Yalu; Yu, Huajian; Wong, Tin Lok; Gao, Yuan; Yun, Jing-Ping; Ma, Stephanie. DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCC. Hepatology ():10.1097/HEP.0000000000001158, November 12, 2024. Min-Yue Zhang; George Calin; Ming-Dan Deng; Rex K. H. Au-Yeung; Lu-Qian Wang; Chor-Sang Chim. Epigenetic Silencing of Tumor Suppressor lncRNA NKILA: Implication on NF-κB Signaling in Non-Hodgkin’s Lymphoma. Genes 2022, 13, 128 . Mingdan Deng; Wei Dai; Valen Zhuoyou Yu; Lihua Tao; Maria Li Lung. Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma. Cancers 2020, 12, 1924 . Hong Zheng; Wei Dai; Arthur Kwok Leung Cheung; Josephine Mun Yee Ko; Rebecca Kan; Bonnie Wing Yan Wong; Merrin Man Long Leong; Mingdan Deng; Tommy Chin Tung Kwok; Jimmy Yu-Wai Chan; Dora Lai-Wan Kwong; Anne Wing-Mui Lee; Wai Tong Ng; Roger Kai Cheong Ngan; Chun Chung Yau; Stewart Tung; Victor Ho-Fun Lee; Ka-On Lam; Chung Kong Kwan; Wing Sum Li; Stephen Yau; Kwok-Wah Chan; Maria Li Lung. Whole-exome sequencing identifies multiple loss-of-function mutations of NF-κB pathway regulators in nasopharyngeal carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2016, 113, 11283 -11288.

Experience

  • Senior Scientist at Innorna (HK) co. limited
    May 2022 - Present · 4 yrs 2 mos

    I am working as a project leader on mRNA drug discovery and development to treat some diseases safely and efficiently.

  • Postdoctoral Researcher at The University of Hong Kong
    Mar 2020 - May 2022 · 2 yrs 3 mos

    Researches on leukemia and liver cancer. Exploring target genes function in tumor development and microenvironment. Also established organoid culturing for primary mouse tumor cells.